Boston Scientific logo

BSX - Boston Scientific Share Price

$39.41 0.1  0.2%

Last Trade - 13/04/21

Large Cap
Market Cap £40.67bn
Enterprise Value £46.06bn
Revenue £7.21bn
Position in Universe 220th / 6841
Unlock BSX Revenue
Relative Strength (%)
1m -2.66%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -7.15%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
7,477 8,386 9,048 9,823 10,735 9,913 11,405 12,363 +5.8%
-24.3 +57.3 +29.5 +43.6 -14.7 -60.5 +263.9 +18.8
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BostonScientific Corporation revenues decreased 8% to $9.91B. Netloss applicable to common stockholders excludingextraordinary items totaled $115M vs. income of $598M.Revenues reflect Rhythm and Neuro segment decrease of 12%to $2.75B, Cardiovascular segment decrease of 8% to $3.88B,United States segment decrease of 10% to $5.51B, EMEA(Europe.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for BSX
Graphical History


BSX Revenue Unlock BSX Revenue

Net Income

BSX Net Income Unlock BSX Revenue

Normalised EPS

BSX Normalised EPS Unlock BSX Revenue

PE Ratio Range

BSX PE Ratio Range Unlock BSX Revenue

Dividend Yield Range

BSX Dividend Yield Range Unlock BSX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BSX EPS Forecasts Unlock BSX Revenue
Profile Summary

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated June 22, 1979
Public Since May 19, 1992
No. of Shareholders: 6,943
No. of Employees: 38,000
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 1,420,516,801
Free Float (0.0%)
Eligible for
BSX Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BSX
Upcoming Events for BSX
Wednesday 28th April, 2021
Q1 2021 Boston Scientific Corp Earnings Call
Wednesday 28th April, 2021
Q1 2021 Boston Scientific Corp Earnings Release
Wednesday 5th May, 2021
Boston Scientific Corp at Truist Securities Life Sciences Summit
Thursday 6th May, 2021
Boston Scientific Corp Annual Shareholders Meeting
Friday 7th May, 2021 Estimate
Boston Scientific Corp Annual Shareholders Meeting
Tuesday 27th July, 2021 Estimate
Q2 2021 Boston Scientific Corp Earnings Release
Frequently Asked Questions for Boston Scientific
What is the Boston Scientific share price?

As of 13/04/21, shares in Boston Scientific are trading at $39.41, giving the company a market capitalisation of £40.67bn. This share price information is delayed by 15 minutes.

How has the Boston Scientific share price performed this year?

Shares in Boston Scientific are currently trading at $39.41 and the price has moved by 6.82% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Boston Scientific price has moved by -28.55% over the past year.

What are the analyst and broker recommendations for Boston Scientific?

Of the analysts with advisory recommendations for Boston Scientific, there are there are currently 11 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Boston Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Boston Scientific next release its financial results?

Boston Scientific is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Boston Scientific dividend yield?

Boston Scientific does not currently pay a dividend.

Does Boston Scientific pay a dividend?

Boston Scientific does not currently pay a dividend.

When does Boston Scientific next pay dividends?

Boston Scientific does not currently pay a dividend.

How do I buy Boston Scientific shares?

To buy shares in Boston Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Boston Scientific?

Shares in Boston Scientific are currently trading at $39.41, giving the company a market capitalisation of £40.67bn.

Where are Boston Scientific shares listed? Where are Boston Scientific shares listed?

Here are the trading details for Boston Scientific:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: BSX
What kind of share is Boston Scientific?

Based on an overall assessment of its quality, value and momentum, Boston Scientific is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Boston Scientific share price forecast 2021?

Shares in Boston Scientific are currently priced at $39.41. At that level they are trading at 10.22% discount to the analyst consensus target price of 0.00.

Analysts covering Boston Scientific currently have a consensus Earnings Per Share (EPS) forecast of 1.536 for the next financial year.

How can I tell whether the Boston Scientific share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Boston Scientific. Over the past six months, the relative strength of its shares against the market has been -18.29%. At the current price of $39.41, shares in Boston Scientific are trading at 5.03% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Boston Scientific PE Ratio?

The Boston Scientific PE ratio based on its reported earnings over the past 12 months is 93.19. The shares are currently trading at $39.41.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Boston Scientific?

Boston Scientific's management team is headed by:

Nelda Connors - IND
Joseph Fitzgerald - EVP
Michael Mahoney - CHM
David Pierce - EVP
Jeffrey Mirviss - EVP
Daniel Brennan - CFO
Edward Ludwig - LED
Donna James - IND
Edward Mackey - EVP
Eric Thepaut - EVP
Charles Dockendorff - IND
Yoshiaki Fujimori - IND
Arthur Butcher - EVP
Ian Meredith - EVP
Jodi Eddy - SVP
Who are the major shareholders of Boston Scientific?

Here are the top five shareholders of Boston Scientific based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.8% (110.8m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 5.44% (77.3m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.86% (69.1m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.58% (65.1m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 4.09% (58.1m shares)
Similar to BSX
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.